Preventive injection of some types of pain-relief drugs around knee joint for management of pain after complete replacement of knee joint.

Not Applicable

• Conditions: Condition 1: Arthrosis of knee (Gonarthrosis). Condition 2: Severity of pain after Total Knee Arthroplasty. Condition 3: Total Knee Arthroplasty.; Other primary gonarthrosis; Other complications of internal orthopaedic prosthetic devices, implants and grafts; Presence of other specified functional implants

• Registration Number: IRCT2016073129132N2
• Lead Sponsor: Isfahan University of Medical Sciences and Health Cares.

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 120

Inclusion Criteria

individuals with osteoarthritis who were scheduled for primary unilateral TKA.
Exclusion criteria: BMI greater than 40; previous history of allergy to any medications; known abuser of alcohol and other drugs; any inflammatory arthritis; previous major surgery in the same knee joint indicated for TKA; individuals who were candidated for bilateral TKA; patients who did not show up for the follow-up.

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The severity of the pain in knee joint. Timepoint: 24 hours, 48 hours and 6 weeks after the surgery. Method of measurement: Visual Analog Scale (VAS).

Secondary Outcome Measures

Name	Time	Method
Function of knee joint. Timepoint: 6 weeks and 6 months after surgery. Method of measurement: Knee Society Score.